Background: Many neuromuscular blockers act as negative allosteric modulators of muscarinic acetylcholine receptors by decreasing affinity and potency of acetylcholine. The neuromuscular blocker ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

This process of informed clinical observation followed by scientific confirmation is now excitingly poised to usher in a new generation of treatments for schizophrenia and psychosis based on targeting ...

A drug that has recently been approved for the treatment of schizophrenia could one day be prescribed to Alzheimer’s patients ...